Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 55.3 TWD 0.55%
Market Cap: 14.6B TWD

Wall Street
Price Targets

Price Targets Summary
Tanvex BioPharma Inc

There are no price targets for Tanvex BioPharma Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tanvex BioPharma Inc Competitors:
Price Targets
EDT
Spectral Medical Inc
129% Upside
PHIL
Philogen SpA
14% Upside
VRTX
Vertex Pharmaceuticals Inc
11% Upside
SYNACT
SynAct Pharma AB
18% Upside
CDNA
CareDx Inc
23% Upside
CANTA
Cantargia AB
95% Upside
RYTM
Rhythm Pharmaceuticals Inc
32% Upside
CELC
Celcuity Inc
12% Upside

Revenue
Forecast

Revenue Estimate
Tanvex BioPharma Inc

The compound annual growth rate of Tanvex BioPharma Inc's revenue for the next 2 years is 516%.

N/A
Past Growth
516%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tanvex BioPharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

Net Income Estimate
Tanvex BioPharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tanvex BioPharma Inc's stock price target?
Not Available

Tanvex BioPharma Inc doesn't have any price targets made by Wall Street professionals.

What is Tanvex BioPharma Inc's Revenue forecast?
Projected CAGR
516%

The compound annual growth rate of Tanvex BioPharma Inc's revenue for the next 2 years is 516%.

Back to Top